Amyotrophic lateral sclerosis Trials in Phoenix, United States
Conditions / Amyotrophic lateral sclerosis / Phoenix, United States
Clinical trials for Amyotrophic lateral sclerosis investigate a range of treatment strategies and patient populations.
56 total trials for this combination
Showing top 10 of 56 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01709149 | Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) | COMPLETED | PHASE2 |
| NCT04297683 | HEALEY ALS Platform Trial - Master Protocol | RECRUITING | — |
| NCT04248465 | An Efficacy and Safety Study of Ravulizumab in ALS Participants | TERMINATED | PHASE3 |
| NCT01622088 | Phase 3 Extension Study of Dexpramipexole in ALS | TERMINATED | PHASE3 |
| NCT02496767 | Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year | COMPLETED | PHASE3 |
| NCT03505021 | Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS | COMPLETED | PHASE3 |
| NCT05021536 | Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01281189 | Phase 3 Study of Dexpramipexole in ALS | COMPLETED | PHASE3 |
| NCT04944784 | A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) | TERMINATED | PHASE3 |
| NCT03160898 | A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) | COMPLETED | PHASE2 |